Here are three highlights:
1. The patents strengthen VTI’s suite of patents covering its modular device design.
2. Currently, VTI possess 28 patents and patent-pending assets.
3. VTI’s InterFuse System features intraoperative assembly technology, which creates a large implant footprint via a minimally invasive approach.
More articles on devices:
Device tax repeal likely: 5 thoughts from AdvaMed President Scott Whitaker
OrthAlign taps Andy Turner to run operations in Australia and New Zealand — 4 key notes
Global bone growth stimulators market — Spinal fusion segment led in 2016
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
